Adze Biotechnology
Business Services · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
805 Lake St 126, Oak Park, Illinois, 603...Phone Number
(917) 743-9401Website
www.adzebiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Adze Biotechnology
Adze Biotechnology is a clinical stage company focused on developing a platform of oncolytic immunotherapies aimed at treating solid tumors and enhancing anti-tumor immunity. Their innovative approach utilizes a proprietary oncolytic viral backbone for systemic delivery of immunotherapies and checkpoint inhibitors. The company targets multiple solid tumor indications, including melanoma, hepatocellular carcinoma, and triple-negative breast cancer. Adze Biotechnology aims to build strategic partnerships with major pharmaceutical companies to advance their drug candidates and improve patient outcomes.Explore more
Popular SearchesAdze BiotechnologyAdze BioTechnology IncBiotechnology IncSIC Code 87,873NAICS Code 54,541Show moreAdze Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adze Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Adze Biotechnology launches new products
Check out if Adze Biotechnology is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Adze Biotechnology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Adze Biotechnology had a recent Job posting/layoffs
Check if Adze Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Adze Biotechnology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Adze Biotechnology
Adze Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Adze Biotechnology
Find more new buyers
Compare Similar Companies to Adze Biotechnology
Compare insights from companies similar to Adze Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Adze Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adze Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adze Biotechnology.
Adze Biotechnology financials insights
Gather financial insights about Adze Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$3.5M
Adze Biotechnology Tech Stack
A closer look at the technologies used by Adze Biotechnology
Most Recent Scoops
Project
Research & Development, Safety, Medical Research, Pharmaceuticals, Clinical Operations, Health & Safety, Regulations
Facilities Relocation / Expansion
Adze Biotechnology is planning to move its offices in July 2021. The move will impact employees at their existing office located at 805 Lake St. , 126, Oak Park, IL.
Real Estate
Funding
Funding
Adze Biotechnology News & Media
Adze Biotechnology Submits Bellberry HREC Application for Adze1.C Clinical Trial in Australia
The Bellberry application is a key regulatory milestone, advancing Adze’s commitment to initiating clinical studies of its immunotherapy candidate, Adze1.C, CORAL GABLES, FLORIDA, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- Adze Biotechnology, …Paola Grandi, PhD, MBA, Joins Adze Biotechnology to Lead Pre-Clinical and Translational Research Programs.
ADZE is thrilled to welcome Dr. Paola Grandi to our team as we advance our pipeline of systemically deliverable oncolytic immunotherapies into the clinic. CORAL GABLES, FLORIDA, US, April 8, 2024 /EINPresswire.com/ -- Dr. Paola Grandi, PhD, MBA is the …ADZE Biotechnology Reports US Patent Office Grants Patent Claiming Novel Recombinant Adenovirus
ADZE is a biopharmaceutical company focused on novel cancer therapeutics for a broad range of cancer indications. CORAL GABLES, FLORIDA, US, September 14, 2023 /EINPresswire.com/ -- ADZE Biotechnology Announces Notice of Allowance from US Patent and …Adze Biotechnology Announces Members of Scientific Advisory Board
The Adze Scientific Advisory Board will provide important counsel in the years ahead, with research & development”, Sidney Hopps, Co-Founder & CEO Adze CORAL GABLES, FLORIDA, US, August 2, 2023 /EINPresswire.com/ -- Coral Gables, August 2, 2023 …
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Adze Biotechnology
Sign Up For FreeTo access detailed company insights
Adze Biotechnology is a clinical stage company focused on developing a platform of oncolytic immunotherapies aimed at treating solid tumors and enhancing anti-tumor immunity. Their innovative approach utilizes a proprietary oncolytic viral backbone for systemic delivery of immunotherapies and checkpoint inhibitors. The company targets multiple soli... Read More
